| |
|
|
|
NovaBay Pharmaceuticals Inc.  
|
|
0.69 -0.096 (-0.12%) |
09-20 16:00 |
|
Open: |
0.71 |
Pre close: |
0.7865 |
Target:
|
0.96
|
|
High: |
0.775 |
Low: |
0.641 |
Resistance:
|
0.82
0.96
|
|
Volume: |
2,176,246 |
Market Cap: |
17M |
Support:
|
0.57
0.42
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.64
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
0.56 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
0.99  |
Stochastic Oscillator |
%K(14,3):
|
80.61 |
|
MA(250): |
1.19 |
%D(3): |
67.18 |
|
Average Volume(K) |
3-Month: |
106410
|
52-Week |
High:
|
4.04 |
|
10-Days: |
230734 |
Low: |
0.23 |
|
RSI |
RSI(14):
|
51.81 |
Change(%): |
-65.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.584 |
Return on Equity (ttm) |
-208.8 |
Shares Out. (M) |
25.20 |
|
EPS Est. Current Year |
-0.470 |
Return on Assets (ttm) |
-51.4 |
Shares Float (M) |
8.69 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
25.87 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
-36.0 |
% Held by Institutions |
4.11 |
|
Forward EPS |
-0.170 |
Gross Profit (p.s.) |
0.437 |
Shares Short (K) |
354 |
|
Book Value (p.s.) |
0.080 |
EBITDA (p.s.) |
-0.345 |
P/E |
-1.18 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.63 |
|
Profit Margin |
-94.52 |
Operating Cash Flow
(M) |
-8.61 |
P/S |
30505262.00 |
|
Operating Margin |
-88.29 |
Levered Free Cash Flow
(M) |
-5.23 |
P/CF |
-2.02 |
|
|
|
|
|
|
